Join to view full profile
988102 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-559-5600
Fax+1 402-559-4835
Dr. Grem is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1983 - 1986
University of Iowa Health Care Medical CenterResidency, Internal Medicine, 1980 - 1983
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1980
Certifications & Licensure
NE State Medical License 2003 - 2028
WI State Medical License 1983 - 2003
IA State Medical License 1980 - 1985
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
- UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors
- Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Start of enrollment: 2004 Feb 25
Publications & Presentations
PubMed
- Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis.Venkatesh Varadharaj, Frank Leon, Nivedeta Krishna Kumar, Palanisamy Nallasamy, Pratima Raut
Oncogene. 2026-09-01 - 2 citationsThe circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion.Lan Wang, Chris R Harris, Crissy Dudgeon, Orjola Prela, Juliana Cazarin
Developmental Cell. 2026-06-10 - 1 citationsAntithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesis.Thomas Mandel Clausen, Ryan J Weiss, Jacob R Tremblay, Benjamin P Kellman, Joanna Coker
The Journal of Clinical Investigation. 2025-11-17
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: